Navigation Links
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Date:6/9/2008

n on schedule to initiate our second AZ-004 Phase 3 study during the third quarter of this year."

AZ-004 Phase 3 Clinical Trial Design

The first AZ-004 Phase 3 clinical trial enrolled 344 patients with schizophrenia at 24 U.S. clinical centers. The trial is an in-clinic, multi-center, randomized, double-blind, placebo-controlled study, testing AZ-004 at two dose levels, 5 and 10 mg. The trial protocol specified that patients were eligible to receive up to 3 doses of study drug in a 24-hour period, depending on their clinical status.

The primary endpoint for the study is the reduction in agitation as measured by the change from baseline in the PEC Score, measured at 2 hours after the first dose. The PEC Score is a commonly used endpoint in acute agitation studies and is the abbreviation for PANSS (Positive and Negative Symptom Scale) Excited Component Score. The trial protocol specified that various assessments of a patient's agitation state be conducted at serial time points using standard agitation scales over the first 4-hour post-dose time period, with follow-up assessments at the end of the 24-hour study period. Side effects were recorded throughout the 24-hour period.

Alexza projects that the initial results will be reported before the end of September 2008. The second Phase 3 clinical trial is projected to begin in Q3 2008. The design of the second study will be similar to the first trial, except that the patient population will be bipolar disorder patients.

Conference Call Information

The Company will host an investor conference call to discuss today's announcement on Monday, June 9, 2008 at 5:15 p.m. Eastern Time. A replay of the call will be available for two weeks following the event. The conference call, replay and webcast are open to all interested parties.

Domestic callers: 1-800-299-0148

International callers: 1-617-801-9711

Passcode: 11378886

Webcast information:

<
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of ... Forecasts, 2012-2018"  report to their offering. Global Guidewires ... The North America accounts for ... Europe claims approximately 25% (2018). ...
(Date:12/15/2014)... 2014  Colorado and Washington State ... of cannabis. Oregon , Alaska ... prohibition during the November 2014 elections. Photo ... The benefits of legalizing cannabis are ... like the increased tax revenue for state and local governments, ...
(Date:12/15/2014)... Government of Ghana has endorsed a project ... Terumo BCT to respond to the emerging Ebola crisis within ... system capacity to the citizens of Ghana . ... and Resilience Initiative (GERRI) is a multi-agency effort designed to: ... arrival of the Ebola epidemic , Provide new blood product ...
Breaking Medicine Technology:Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6
... ("Unilife" or the "Company") (NASDAQ: UNIS ; ... the fourth quarter and fiscal year ended June 30, ... Completed construction of new global headquarters and commercial production ... (December 2010) Appointed Dr. Ramin Mojdeh as Chief ...
... AUSTIN, Texas, Aug. 30, 2011 Luminex Corporation (Nasdaq: ... present at two upcoming investment conferences, the Morgan Stanley ... Conference, both scheduled to take place in New York ... Patrick J. Balthrop, president and chief executive ...
Cached Medicine Technology:Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 2Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 3Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 4Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 5Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 6Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 7Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 8Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 9Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011 10Luminex Corporation to Present at Upcoming Investment Conferences In September 2
(Date:12/17/2014)... 2014 A group of 127 scientists sent ... in reaction to a recent statement by the center that ... and derogated the efficacy of all brain exercises. , Signatories ... parts of the center’s statement critical of brain exercise companies ... also overstated its case, in a document it had entitled ...
(Date:12/17/2014)... 2014 Project Veritas is releasing a ... of MIT economist and Obamacare architect Jonathan Gruber to ... conducted the interview, which is being distributed on YouTube. ... intentional mislabeling in the Affordable Care Act in order ... two-hundred-and-fifty billion dollar per year tax grab. , “President ...
(Date:12/17/2014)... students get more fruits and vegetables at school than they ... opposite is true for students from wealthier families. These ... give a healthy boost to poor students, diets, according to ... level, students all ate a similar amount of fruits and ... published recently in the journal Preventive Medicine . ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... in America, and work commitment is a big reason why, ... killer," said Dr. Mathias Basner, an assistant professor of sleep ... School of Medicine. A time-use survey of nearly 125,000 ... the main activity exchanged for sleep. Short sleepers -- those ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ... on a new study providing evidence on the impact ... of children. , Sufficient enough evidence already exists showing ... or juice drinks, with the onset of tooth decay. ... drinks listed as 100% fruit juice, meaning it is ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2
... , , , ... this fall, U.S. public health officials and other leading medical experts ... protection against seasonal influenza - a threat to Americans, health each ... is already available in many communities and Americans should begin to ...
... September 2009 - Drug treatment options for depression can ... is clearly inadequate for those at immediate risk of ... used as an anesthetic, has shown rapid antidepressant effects ... effects on suicidality in patients with treatment-resistant depression, and ...
... , HAYWARD, Calif., Sept. 10 Solta ... the launch of the new Thermage CPT and Fraxel re:store Dual ... ( www.illumiNATIONtour.com ). Starting September 14 and continuing through ... and Fraxel(R) systems directly to physicians in over 20 cities across ...
... , HOUSTON, Sept. 10 Cyberonics, ... President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, ... York on Tuesday, September 22, 2009 at 4:00 PM EDT. ... replay at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=82_IT8KY1C . The replay will ...
... LITTLE FALLS, N.J., Sept. 10 CANTEL MEDICAL ... A. Krakauer, President & CEO, will be presenting at the UBS ... AM ET on Tuesday, September 22, 2009 at the Grand Hyatt ... presentation. In addition, Mr. Krakauer and Seth R. Segel, Executive Vice ...
... resulted in roughly same outcome, research shows , ... workers with mental health problems return to near-normal productivity, ... mental stress seemed to have the same effect, researchers ... regarding mental health and productivity levels in more than ...
Cached Medicine News:Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 2Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 3Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 4Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 5Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 6Health News:Solta Medical Launches illumiNATION tour in U.S. and Europe to Introduce New Thermage CPT(TM) and Fraxel re:store(R) Dual Systems 2Health News:Solta Medical Launches illumiNATION tour in U.S. and Europe to Introduce New Thermage CPT(TM) and Fraxel re:store(R) Dual Systems 3Health News:Cyberonics to Present at UBS Global Life Sciences Conference 2Health News:Treating Workers' Mental Woes May Boost Productivity 2
Inquire...
Inquire...
Nature's Remarkable Skin Protector -- Karaya 5 is a natural skin barrier that is particularly well suited for skin problems or for sensitive skin where reactions may have occurred to other types of s...
Superior Skin Care...FlexWear skin barrier provides skin protection for an extended wear time....
Medicine Products: